Transcription factors are multidomain proteins that serve as key regulators of gene expression by enabling precise transcriptional control. In this study, we expanded the gold nanoparticle–based artificial transcription factor platform, NanoScript, ...
Transcription factors are multidomain proteins that serve as key regulators of gene expression by enabling precise transcriptional control. In this study, we expanded the gold nanoparticle–based artificial transcription factor platform, NanoScript, by developing a NanoScript-TFO (NS-T) system that employs a triplex-forming oligonucleotide (TFO) as the DNA-binding domain. By incorporating TFOs, this platform minimizes competition with endogenous transcription factors and enables a novel transcriptional regulation strategy targeting non-coding regulatory DNA regions. NS-T exhibited high stability under physiological conditions, showed no detectable cytotoxicity, and achieved efficient nuclear localization. By modulating the orientation of the gold nanoparticle and the genomic position of the target site, we identified that transcriptional activation was most effective when NS-T targeted non-coding DNA with the gold nanoparticle positioned downstream. Application of NS-T, designed with optimized TFO sequences, to human iPSC-derived satellite-like cells resulted in upregulation of a broad range of myogenic genes, including MYOD and MYOG, and led to accelerated myotube formation. Collectively, the NS-T platform presented in this study offers a safe, non-viral, and rationally designable approach for gene regulation, highlighting its broad technological potential for applications in skeletal muscle regeneration as well as diverse fields of regenerative medicine and transcriptional modulation research.